As regards spiromesifen, such an application was made for tea. The applicant claims that the authorised use of spiromesifen on such crop in Japan, India and Indonesia leads to residues exceeding the MRL authorised under Regulation (EC) No 396/2005 and that a higher MRL is necessary to avoid trade barriers for the importation of tea.
Recital 5, Commission Regulation (EU) No 500/2013 of 30 May 2013 amending Annexes II, III and IV to…
In forcesince 30 May 2013